fashion -WSS

fashion

author：hotspot 2025-09-29 18:15:45 - browse：96

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Paxlovid study fails to answer questions over benefit for broader groups

hotspot

WSS

Colonoscopy at 40? Study finds a possible benefit

Weight bias in eating disorder treatment complicated by new weight loss drugs

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Positive childhood experiences can help future health

Paxlovid study fails to answer questions over benefit for broader groups

hotspot

fashion

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Intermittent fasting comes with a heart risk? Not so fast

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What would happen to your eyes if you looked at the solar eclipse?

Malaria cases in Florida and Texas: Here’s what you need to know

Why are elite athletes different? Take a look at their microbes

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ask STAT: What do you want to know about ChatGPT in medicine?

entertainment

Physicians and social media: If you see something, say something?

App could help diagnose ear infections more accurately — and at home

Gene editing the human germline: What are the risks?

New guidelines on severe brain injury complicate already difficult decisions

Paxlovid study fails to answer questions over benefit for broader groups

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

focus

hotspot

Wikipedia

hotspot